Why do cancers develop differently in different people—even when they are exposed to the same risk factors? An international ...

Ovarian cancer is often called the ‘silent killer’ because of the symptoms, which can be vague and easily mistaken for minor ...

The Lung Cancer Genetics Study aims to identify genetic variations linked to lung cancer, enhancing risk assessments and treatment strategies. Collaboration between 23andMe and lung cancer advocates ...

Testing thousands of genes in living tumors revealed hidden drivers of aggressive basal-like breast cancer that cell cultures ...

Confluence Genetics today announced the launch of Cas-CLEAR™, Collaterally Enhanced Activated Ribonuclease, a new CRISPR technology platform for the treatment of cancers carrying defined genetic ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, can cause aggressive disease at a young age.

Breast cancer is the most common cancer in women worldwide. In sub-Saharan Africa, it is a leading cause of cancer-related deaths among women. Risk factors for developing breast cancer include being ...

Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...

Scientists have found that genetics and type of cancer treatment contribute most to a survivor's risk of a second cancer. Physicians caring for survivors of childhood cancer later in life should be ...

NewYork-Presbyterian's program offers self-referred genetic testing, focusing on personalized cancer prevention and care.